TriSalus Life Sciences, Inc.
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.
On April 24, 2026, Jodi Devlin provided notice to TriSalus Life Sciences, Inc. (the “Company”) of her intention to retire from her role as Chief of Clinical Operations, effective October 1, 2026.
As previously announced on April 7, 2026, the Company appointed Dr. Richard Marshall to Chief Medical Officer of the Company, effective June 29, 2026.
Extracted from this filing and checked against the source text.
Jodi Devlin departed as Chief of Clinical Operations at TriSalus Life Sciences, Inc..
On April 24, 2026, Jodi Devlin provided notice to TriSalus Life Sciences, Inc. (the “Company”) of her intention to retire from her role as Chief of Clinical Operations, effective October 1, 2026.View on SEC.gov
Dr. Richard Marshall was appointed as Chief Medical Officer at TriSalus Life Sciences, Inc..
As previously announced on April 7, 2026, the Company appointed Dr. Richard Marshall to Chief Medical Officer of the Company, effective June 29, 2026.View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.